307 related articles for article (PubMed ID: 20048433)
21. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
22. [Contribution of the CoLaus study to decipher the determinants of serum uric acid].
Bochud M; Vollenweider P; Waeber G
Rev Med Suisse; 2011 Nov; 7(315):2142, 2144-5. PubMed ID: 22187784
[TBL] [Abstract][Full Text] [Related]
23. [Other antihyperuricemic agents].
Ogino K; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
[TBL] [Abstract][Full Text] [Related]
24. The role of hyperuricemia in vascular disorders.
Edwards NL
Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
[TBL] [Abstract][Full Text] [Related]
25. [Calcium antagonists: current and future applications based on new evidence. Effects of calcium channel blockers on oxidative stress].
Nishiyama A; Nakano D; Hitomi H
Clin Calcium; 2010 Jan; 20(1):38-44. PubMed ID: 20048432
[TBL] [Abstract][Full Text] [Related]
26. Hyperuricaemia: more than just a cause of gout?
Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
[TBL] [Abstract][Full Text] [Related]
27. [Serum uric acid--a cardiovasular risk factor?].
Alderman M; Redfern JS
Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
[TBL] [Abstract][Full Text] [Related]
28. [Differential therapy with calcium antagonists].
Scholze JE
Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
[TBL] [Abstract][Full Text] [Related]
29. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
Kanellis J; Feig DI; Johnson RJ
Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
[TBL] [Abstract][Full Text] [Related]
30. [Calcium antagonists: current and future applications based on new evidence. Renal protective action of calcium channel blockers].
Kimura G
Clin Calcium; 2010 Jan; 20(1):94-9. PubMed ID: 20048440
[TBL] [Abstract][Full Text] [Related]
31. Uric acid in hypertension and renal disease: the chicken or the egg?
Kanbay M; Solak Y; Dogan E; Lanaspa MA; Covic A
Blood Purif; 2010; 30(4):288-95. PubMed ID: 21088389
[TBL] [Abstract][Full Text] [Related]
32. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
Sierra C; Coca A
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
[TBL] [Abstract][Full Text] [Related]
33. [Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers].
Takahara A
Clin Calcium; 2010 Jan; 20(1):24-30. PubMed ID: 20048430
[TBL] [Abstract][Full Text] [Related]
34. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
Baker JF; Krishnan E; Chen L; Schumacher HR
Am J Med; 2005 Aug; 118(8):816-26. PubMed ID: 16084170
[TBL] [Abstract][Full Text] [Related]
35. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
36. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
Jalal DI
Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
[TBL] [Abstract][Full Text] [Related]
38. [Which uric acid value is in need of treatment?].
Siegenthaler-Zuber G
Schweiz Med Wochenschr; 1976 Apr; 106(14):487-91. PubMed ID: 1265467
[TBL] [Abstract][Full Text] [Related]
39. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?
Johnson RJ; Segal MS; Srinivas T; Ejaz A; Mu W; Roncal C; Sánchez-Lozada LG; Gersch M; Rodriguez-Iturbe B; Kang DH; Acosta JH
J Am Soc Nephrol; 2005 Jul; 16(7):1909-19. PubMed ID: 15843466
[TBL] [Abstract][Full Text] [Related]
40. Gout and hyperuricemia.
Roubenoff R
Rheum Dis Clin North Am; 1990 Aug; 16(3):539-50. PubMed ID: 2217957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
